{
    "nctId": "NCT04145960",
    "briefTitle": "Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Breast Cancer",
    "officialTitle": "Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Breast Cancer Via Analysis of Immunoinflammation-related Protein Complexes in Blood",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "immune inflammation-related protein complexes",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female\n* Postoperative pathology confirmed invasive breast cancer after surgery for breast tumors\n* Breast cancer-related chemotherapy and radiotherapy completed\n* axillary lymph node metastasis \u2265 4\n* age \u2264 60 years old\n\nExclusion Criteria:\n\n* Male\n* Aged above 60\n* Breast Carcinoma in situ\n* Women in pregnancy or breastfeeding\n* Suffering from other malignant tumors\n* Non-compliant patient",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT"
}